Telemedicine legislation including CONNECT for Health Act; Telemental Health Care Access Act; TREATS Act; Ryan Haight Act/DEA rulemaking on telemedicine; H.R. 1843, S. 1001 - Telehealth Expansion Act; H.R. 824 Telehealth Benefit Expansion for Workers Act; Telehealth Modernization Act; Primary and Virtual Care Affordability Act; Expanding Remote Monitoring Access Act
Telemedicine legislation including CONNECT for Health Act; Telemental Health Care Access Act; Telehealth Modernization Act; Primary and Virtual Care Affordability Act; Expanding Remote Monitoring Access Act
Duration: January 1, 2022
to
present
General Issues: Health Issues , Medicare/Medicaid
Spending: about $1,010,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2022: U.S. Senate, House of Representatives, Health & Human Services - Dept of (HHS), Drug Enforcement Administration (DEA), Executive Office of the President (EOP)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
Kyle Zebley
Legislative Director/Senior Legislative Assistant/Legislative Assistant, Rep. Tom Price (R-GA); Chief of Staff/Senior Advisor, HHS Office of the Secretary
Alexis Apple
n/a
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2024
In Q1, ATA ACTION had in-house lobbyists. The report was filed on April 19.
Original Filing: 301566682.xml
Lobbying Issues
Telemedicine legislation including CONNECT for Health Act; Telemental Health Care Access Act; TREATS Act; Ryan Haight Act/DEA rulemaking on telemedicine; H.R. 1843, S. 1001 - Telehealth Expansion Act; H.R. 824 Telehealth Benefit Expansion for Workers Act; Telehealth Modernization Act; Primary and Virtual Care Affordability Act; Expanding Remote Monitoring Access Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Drug Enforcement Administration (DEA) Executive Office of the President (EOP)
Lobbying Issues
Telemedicine legislation including CONNECT for Health Act; Telemental Health Care Access Act; Telehealth Modernization Act; Primary and Virtual Care Affordability Act; Expanding Remote Monitoring Access Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Drug Enforcement Administration (DEA) Executive Office of the President (EOP)
4th Quarter, 2023
In Q4, ATA ACTION had in-house lobbyists. The report was filed on Jan. 18.
Original Filing: 301527695.xml
Lobbying Issues
Telemedicine legislation including CONNECT for Health Act; Telemental Health Care Access Act; TREATS Act; Ryan Haight Act/DEA rulemaking on telemedicine; H.R. 1843, S. 1001 - Telehealth Expansion Act; H.R. 824 Telehealth Benefit Expansion for Workers Act.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Drug Enforcement Administration (DEA) Executive Office of the President (EOP)
Lobbying Issues
Telemedicine legislation including CONNECT for Health Act; Telemental Health Care Access Act.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Drug Enforcement Administration (DEA) Executive Office of the President (EOP)
3rd Quarter, 2023
In Q3, ATA ACTION had in-house lobbyists. The report was filed on Oct. 18, 2023.
Original Filing: 301503865.xml
Lobbying Issues
Telemedicine legislation including CONNECT for Health Act; Telemental Health Care Access Act; TREATS Act; Ryan Haight Act/DEA rulemaking on telemedicine; H.R. 1843, S. 1001 - Telehealth Expansion Act; H.R. 824 Telehealth Benefit Expansion for Workers Act.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Drug Enforcement Administration (DEA) Executive Office of the President (EOP)
Lobbying Issues
Telemedicine legislation including CONNECT for Health Act; Telemental Health Care Access Act.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Drug Enforcement Administration (DEA) Executive Office of the President (EOP)
2nd Quarter, 2023
In Q2, ATA ACTION had in-house lobbyists. The report was filed on July 11, 2023.
Original Filing: 301474591.xml
Lobbying Issues
Telemedicine legislation including CONNECT for Health Act; Telemental Health Care Access Act; TREATS Act; Ryan Haight Act/DEA rulemaking on telemedicine; H.R. 1843, S. 1001 - Telehealth Expansion Act; H.R. 824 Telehealth Benefit Expansion for Workers Act.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Drug Enforcement Administration (DEA) Executive Office of the President (EOP)
Lobbying Issues
Telemedicine legislation including CONNECT for Health Act; Telemental Health Care Access Act.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Drug Enforcement Administration (DEA) Executive Office of the President (EOP)
1st Quarter, 2023
In Q1, ATA ACTION had in-house lobbyists. The report was filed on April 18, 2023.
Original Filing: 301454863.xml
Lobbying Issues
Telemedicine legislation including CONNECT for Health Act; Telemental Health Care Access Act; TREATS Act; Ryan Haight Act/DEA rulemaking on telemedicine; H.R. 1843, S. 1001 - Telehealth Expansion Act; H.R. 824 Telehealth Benefit Expansion for Workers Act.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Drug Enforcement Administration (DEA)
Lobbying Issues
Telemedicine legislation including CONNECT for Health Act; Telemental Health Care Access Act.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Drug Enforcement Administration (DEA)
4th Quarter, 2022
In Q4, ATA ACTION had in-house lobbyists. The report was filed on Jan. 13, 2023.
Original Filing: 301427227.xml
Lobbying Issues
Telemedicine legislation including H.R. 2903, S. 1512 - CONNECT for Health Act; H.R. 1332, S. 368 - Telehealth Modernization Act; H.R. 366 - Protecting Access to Post-COVID Telehealth Act; H.R. 4058, S. 2061 - Telemental Health Care Access Act; H.R. 6202 - Telehealth Extension Act; H.R. 1647, S. 340 - TREATS Act; H.R. 5981, S. 1704 - Telehealth Expansion Act; H.R. 7353 - Telehealth Benefit Expansion for Workers Act; H.R. 7573, S. 3593 - Telehealth Extension and Evaluation Act; H.R. 4040 - Advancing Telehealth Beyond COVID-19 Act; H.R. 2617 - Consolidated Appropriations Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Drug Enforcement Administration (DEA)
Lobbying Issues
Telemedicine legislation including H.R. 2903, S. 1512 - CONNECT for Health Act; H.R. 1332, S. 368 - Telehealth Modernization Act; H.R. 366 - Protecting Access to Post-COVID Telehealth Act; H.R. 4058, S. 2061 - Telemental Health Care Access Act; H.R. 6202 - Telehealth Extension Act; H.R. 1647, S. 340 - TREATS Act; H.R. 4040 - Advancing Telehealth Beyond COVID-19 Act; H.R. 2617 - Consolidated Appropriations Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Drug Enforcement Administration (DEA)
3rd Quarter, 2022
In Q3, ATA ACTION had in-house lobbyists. The report was filed on Oct. 19, 2022.
Original Filing: 301411692.xml
Lobbying Issues
Telemedicine legislation including H.R. 2903, S. 1512 - CONNECT for Health Act; H.R. 1332, S. 368 - Telehealth Modernization Act; H.R. 366 - Protecting Access to Post-COVID Telehealth Act; H.R. 4058, S. 2061 - Telemental Health Care Access Act; H.R. 6202 - Telehealth Extension Act; H.R. 1647, S. 340 - TREATS Act; H.R. 5981, S. 1704 - Telehealth Expansion Act; H.R. 7353 - Telehealth Benefit Expansion for Workers Act; H.R. 7573, S. 3593 - Telehealth Extension and Evaluation Act; H.R. 4040 - Advancing Telehealth Beyond COVID-19 Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Drug Enforcement Administration (DEA)
Lobbying Issues
Telemedicine legislation including H.R. 2903, S. 1512 - CONNECT for Health Act; H.R. 1332, S. 368 - Telehealth Modernization Act; H.R. 366 - Protecting Access to Post-COVID Telehealth Act; H.R. 4058, S. 2061 - Telemental Health Care Access Act; H.R. 6202 - Telehealth Extension Act; H.R. 1647, S. 340 - TREATS Act; H.R. 4040 - Advancing Telehealth Beyond COVID-19 Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Drug Enforcement Administration (DEA)
2nd Quarter, 2022
In Q2, ATA ACTION had in-house lobbyists. The report was filed on July 20, 2022.
Original Filing: 301389190.xml
Lobbying Issues
Telemedicine legislation including H.R. 2903, S. 1512 - CONNECT for Health Act; H.R. 1332, S. 368 - Telehealth Modernization Act; H.R. 366 - Protecting Access to Post-COVID Telehealth Act; H.R. 4058, S. 2061 - Telemental Health Care Access Act; H.R. 6202 - Telehealth Extension Act; H.R. 1647, S. 340 - TREATS Act; H.R. 5981, S. 1704 - Telehealth Expansion Act; H.R. 7353 - Telehealth Benefit Expansion for Workers Act; H.R. 7573, S. 3593 - Telehealth Extension and Evaluation Act.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Drug Enforcement Administration (DEA)
Lobbying Issues
Telemedicine legislation including H.R. 2903, S. 1512 - CONNECT for Health Act; H.R. 1332, S. 368 - Telehealth Modernization Act; H.R. 366 - Protecting Access to Post-COVID Telehealth Act; H.R. 4058, S. 2061 - Telemental Health Care Access Act; H.R. 6202 - Telehealth Extension Act; H.R. 1647, S. 340 - TREATS Act.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS) Drug Enforcement Administration (DEA)
1st Quarter, 2022
In Q1, ATA ACTION had in-house lobbyists. The report was filed on April 19, 2022.
Original Filing: 301363042.xml
Lobbying Issues
Telemedicine legislation including the CONNECT for Health Act; Telehealth Modernization Act; Protecting Access to Post-COVID Telehealth Act; Telemental Health Care Access Act; Telehealth Expansion Act; H.R. 7353 - Telehealth Benefit Expansion for Workers Act.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
Lobbying Issues
Telemedicine legislation including the CONNECT for Health Act; Telehealth Modernization Act; Protecting Access to Post-COVID Telehealth Act; Telemental Health Care Access Act.
Agencies Lobbied
U.S. Senate U.S. House of Representatives Health & Human Services - Dept of (HHS)
1st Quarter, 2022
ATA ACTION filed a lobbying registration on April 7, 2022 for in-house lobbying efforts, effective Jan. 1, 2022.
Original Filing: 301344048.xml
Issue(s) they said they’d lobby about: Telehealth policy; telemedicine prescribing; Medicare; Medicaid; High-deductible health plans. .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate